Početna › Dijabetes tipa 1 › Florida
Kliničke studije za Dijabetes tipa 1 u državi Florida
30 studija za Dijabetes tipa 1 traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
- Clinical Pharmacology of Miami, Miami
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07803744A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Tallahassee Memorial HealthCare, Tallahassee
U tijeku regrutacijaFaza 3
Od 1 do 35 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Tallahassee Memorial HealthCare, Tallahassee
U tijeku regrutacijaFaza 3
Od 1 do 35 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- University of Florida College of Medicine- Site Number : 8400054, Gainesville
- Encore Medical Research - Hollywood- Site Number : 8400061, Hollywood
- Nemours Children's Speciality Care- Jacksonville- Site Number : 8400040, Jacksonville
- i još 2
U tijeku regrutacijaFaza 3
Od 1 do 25 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Southwest General Healthcare Center, Fort Myers
- University of Florida, Gainesville
- Evolution Research Center, Hialeah
- i još 4
U tijeku regrutacijaFaza 1/2
Od 12 do 35 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Florida, Gainesville
U tijeku regrutacijaFaza 2
Od 4 do 34 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Florida, Gainesville
- University of Miami, Miami
- USF Diabetes Center, Tampa
U tijeku regrutacijaFaza 2
Od 8 do 45 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Florida, Gainesville
- University of Miami, Miami
U tijeku regrutacijaFaza 1/2
Od 9 do 20 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07061574Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
- Nemours Children's Health, Jacksonville
U tijeku regrutacija
Od 8 do 65 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT05268250A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- UHealth Diabetes Research Institute, Miami
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT04786262HLA Demographics Study in Adults With Type 1 Diabetes
- University of Florida- Gainesville, Gainesville
U tijeku regrutacijaOpažajna studija
Od 18 do 55 godina · Oba spola · Ažurirano 28. kol 2026. · NCT06860516SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- University of Florida College of Medicine, Gainesville
- University of Miami - Gables One Tower, Miami
U tijeku regrutacijaFaza 2
Od 5 do 40 godina · Oba spola · Ažurirano 24. kol 2026. · NCT07187531INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- University of Florida, Gainsville
U tijeku regrutacijaFaza 2
Od 6 do 17 godina · Oba spola · Ažurirano 13. kol 2026. · NCT07224321Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
- AdventHealth Translational Research Institute, Orlando
U tijeku regrutacijaFaza 2
Od 18 do 40 godina · Oba spola · Ažurirano 12. kol 2026. · NCT05478707A Study of GNTI-122 in Adults Recently Diagnosed With T1D
- University of Florida - Gainesville, Gainesville
- University of Miami, Diabetes Research Institute, Miami
U tijeku regrutacijaFaza 1
Od 18 do 55 godina · Oba spola · Ažurirano 10. kol 2026. · NCT06919354Adapting Single Sessions Interventions for Type 1 Diabetes
- Nemours Children's Hospital - FL, Orlando
U tijeku regrutacija
Od 12 do 17 godina · Oba spola · Ažurirano 24. srp 2026. · NCT06752369Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
- Nemours Children's Health, Jacksonville
- Nemours Children's Health, Orlando
U tijeku regrutacijaOpažajna studija
Od 6 do 17 godina · Oba spola · Ažurirano 20. srp 2026. · NCT05849753Transdisciplinary Care for Young Adults With Type 1 Diabetes
- Nemours Children's Health, Florida, Orlando
U tijeku regrutacija
Od 17 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT06172166Registry for Stage 2 Type 1 Diabetes
- University of Florida Health- Site Number : 8400035, Gainesville
- Nemours Children's Speciality Care- Jacksonville- Site Number : 8400006, Jacksonville
- University of Miami Miller School of Medicine- Site Number : 8400037, Miami
- i još 2
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 13. tra 2026. · NCT06481904Immune Function and the Progression to T1D
- Kieran McGrail, Gainesville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 0 do 100 godina · Oba spola · Ažurirano 9. tra 2026. · NCT05899439Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- AdventHealth, Orlando
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 24. ožu 2026. · NCT06217302Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
- Diabetes Research Institute, Miami
U tijeku regrutacijaOpažajna studija
Od 18 do 75 godina · Oba spola · Ažurirano 23. ožu 2026. · NCT02000687Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- Diabetes Research Institute, Miami
U tijeku regrutacija
Od 18 do 70 godina · Oba spola · Ažurirano 23. ožu 2026. · NCT01999361Long Term Follow up of Recipients of Functional Islet Allografts
- Diabetes Research Institute, Miami
U tijeku regrutacijaOpažajna studija
Od 18 do 65 godina · Oba spola · Ažurirano 23. ožu 2026. · NCT01999374Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
- Bascom Palmer Eye Institute, Miami
- Diabetes Research Institute, University of Miami Miller School of Medicine, Miami
U tijeku regrutacijaFaza 1/2
Od 18 do 75 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT02846571Closed Loop and Education for Hypoglycemia Awareness Restoration
- AdventHealth, Orlando
U tijeku regrutacija
Od 18 do 75 godina · Oba spola · Ažurirano 3. ožu 2026. · NCT06325202Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
- Diabetes Research Institute, University of Miami Miller School of Medicine, Miami
U tijeku regrutacijaFaza 1/2
Od 18 do 35 godina · Oba spola · Ažurirano 19. velj 2026. · NCT05626712Twiist Postmarket Surveillance Study for Type 1 Diabetes
- Jaeb Center for Health Research, Tampa
U tijeku regrutacijaOpažajna studija
Od 6 godina i više · Oba spola · Ažurirano 21. sij 2026. · NCT07356089Precision Administration of Anti-thymocyte Globulin With or Without Verapamil
- University of Florida, Gainesville
U tijeku regrutacijaFaza 2
Od 6 do 35 godina · Oba spola · Ažurirano 26. stu 2025. · NCT06455319TrialNet Pathway to Prevention of T1D
- University of Florida, Gainesville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 2 do 45 godina · Oba spola · Ažurirano 1. srp 2025. · NCT00097292Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.